GlassScriptPhysician profile
Joseph V Cerami
NPI 1639231590
$13,949.58
in general payments reported to CMS, 2019-2025
34 companies · $320 in 2025
The $320 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $854 · 2020: $443 · 2021: $5,641 · 2022: $4,811 · 2023: $1,168 · 2024: $712 · 2025: $320.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,794 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $392 · Consulting Fee: $15.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,794.15 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $391.70 |
| Consulting Fee | $15.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $8,172.15 | 2021-2023 | |
| Baxter Healthcare | $1,113.77 | 2022-2025 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Medtronic, INC. | $728.37 | 2022-2025 | Mycarelink, Micra |
| Pfizer INC. | $483.66 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $384.03 | 2019-2024 | Xarelto |
| Abbott Laboratories | $358.91 | 2019-2025 | Aveir, Amplatzer Amulet |
| E.R. Squibb & Sons, L.L.C. | $316.95 | 2019-2024 | Camzyos |
| Astellas Pharma US INC | $289.39 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $264.95 | 2019-2024 | Farxiga, Wainua |
| Novartis Pharmaceuticals Corporation | $224.31 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $208.77 | 2022-2025 | Verquvo, Capvaxive |
| Boehringer Ingelheim Pharmaceuticals, INC. | $164.33 | 2020-2024 | Jardiance |
| Heartflow, INC. | $148.87 | 2023-2025 | Ffrct |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $148.82 | 2019-2024 | Lifevest |
| Shockwave Medical, INC | $147.80 | 2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $124.22 | 2019-2023 | |
| Kiniksa Pharmaceuticals International, Plc | $90.54 | 2024 | Arcalyst |
| Philips North America LLC | $84.41 | 2020 | |
| Amarin Pharma, INC. | $52.43 | 2019-2021 | |
| Cvrx, INC. | $45.39 | 2023-2024 | Barostim Neo System |
| Kiniksa Pharmaceuticals, LTD. | $42.22 | 2022 | |
| Amgen INC. | $41.66 | 2019-2023 | Repatha |
| Medicomp INC | $40.04 | 2020 | |
| Novo Nordisk INC | $38.92 | 2023-2025 | Wegovy |
| Boston Scientific Corporation | $38.19 | 2021-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $33.90 | 2025 | |
| Bardy Diagnostics, INC. | $32.50 | 2020-2022 | |
| Kestra Medical Technology Services, INC. | $29.67 | 2024 | Assure Wcd |
| Alnylam Pharmaceuticals INC. | $21.36 | 2021 | |
| Amryt Pharma Holdings LTD | $18.62 | 2021 | |
| Angiodynamics, INC. | $16.61 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $16.40 | 2023 | Inpefa |
| Eisai INC. | $15.00 | 2022 | |
| Preventice Services, LLC | $12.42 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Cerami listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.